Highlights from the 5th ESMINT Congress
24 October, 2013 - 11:02

ESMINT Newsletter - Grey Matter
The Newsletter of the European Society of Minimally Invasive Neurological Therapy

István Szikora & Christophe Cognard

István Szikora & Christophe Cognard
> See more pictures from ESMINT Congress 2013


Last month in Nice we celebrated the 5th anniversary of the ESMINT Congress. This year's conference was particularly inspiring and educational thanks to the joint day with our friends from neurosurgery and the interesting discussions on stroke that gave us some important strategic directions for further studies. We also learned a great deal about the diversity of medicine from all over Europe.

Your case submissions make our meeting really interesting and useful so a huge thank you to everyone who participated; the sharing of your knowledge and experiences is very important for our society.

While the annual Congress is clearly a highlight of our society’s activity, ESMINT offers its members much more. By joining the society you can become part of a joint effort to improve and advance minimally invasive treatment of neurological disease, particularly at the dawn of successful treatment of acute ischemic stroke!

If you are already a member of ESMINT you can sign in to to view the case presentations and photos from this year's congress. If you are not yet a member, we urge you to join us; the sooner the better! It is worth being part of ESMINT now!

Thanks for coming to Nice, we hope to see many of you in Barcelona at the ESMINT Teaching Course soon in December.

Christophe Cognard
President of ESMINT

István Szikora

President of the 5th ESMINT Congress


ESMINT Congress 2013

Congress Highlights

The goal of this year's conference was to provide a platform for debate about the present and future of neurovascular disease management with perspectives from different specialisms.

A major highlight was the first ever joint meeting with the Vascular section of the EANS (European Association of Neurological Surgeons) and this new initiative was very much welcomed by the representatives of both interventional and open surgical neurovascular specialists.

ESMINT Congress 2103 Audience

The audience at the 5th ESMINT Congress, 2013
> See more pictures from ESMINT Congress 2013

The two main topics of the joint meeting were the management of giant aneurysms and brain arteriovenous malformations. The surgical and interventional lectures on giant aneurysm disease gave clear insight to both surgical and endovascular reconstructive and obstructive treatment modalities.

Interesting case discussions followed and allowed for in-depth assessment of common problems related to this disease group. The AVM section focused on endovascular, surgical and radiosurgical management of brain AVMs.

On the second day we looked at acute stroke management, an area of increasing importance. The diverse group of presenters created a lively forum for a meaningful exchange of information, including topics like specific imaging, acute treatment modalities, new studies and future perspectives.

Based on the presented data a consensus was achieved that only well-designed studies, with accurate patient selection, are able to show the usefulness of acute endovascular stroke therapy.

On the final day our colleagues from Central-Eastern European countries highlighted the problems they face, and will continue to face while trying to implement state-of-the-art interventional therapies. The programme finished with discussions on intra-aneurysmal flow disruption modalities, intracranial venous disease management and skull-base tumor management.

A great strength of our meeting is its informal style with expert referrals on the hottest topics followed by difficult/interesting case presentations. Debate has always been a positive characteristic of our community, and this collaborative atmosphere ensured heated discussions continued throughout the three days!

Save the date for the 6th Annual Congress that will be taking place in Nice from the 4th-6th September 2014. We look forward to seeing you there!

Zsolt Kulcsar

ESMINT Congress 2013

Congress 2013 Case Presentations
24 September, 2013 - 14:39

Click here to review selected case presentations from the 5th ESMINT Congress (Members only)

> More

Latest Cases
5 September, 2013 - 10:19

Flow Diversion - Can we be sure the clot inside the aneurysm is stable?
> More

Dissecting aneurysm of the superior cerebellar artery. Consider our approach.
> More

ESMINT Device Directory
1 September, 2013 - 01:09

ESMINT Device DirectoryAnnouncing the BETA release of the ESMINT Device Directory

We are delighted to announce the BETA release of the new ESMINT Device Directory on the ESMINT portal.

Working together with our partners Cache Ltd and our colleagues from Industry we have developed a comprehensive portal for technical and educational information about the devices you use.

Access the ESMINT Directory here

Benefits of the directory include:

  • Get a better understanding of the devices you use and the latest product and industry news.
  • Get a quick summary of commercial devices from different Industry suppliers.
  • Save time and effort finding relevant up-to-date technical information.
  • Make effective comparisons between technical literature more easily.
  • Get fast access to publications relating to devices and results.
  • Access a portfolio of material for different treatment indications.
  • Show patients or relatives of patients the kinds of procedures that are used and how they are carried out.

How to access the directory

Click here to access the ESMINT Directory or click on 'DIRECTORY' in the site menu.

If you cannot remember your password you can request a reminder, or contact for further assistance.

Congress 2012
26 March, 2013 - 09:55

Presentations and a selection of photograph's from ESMINT Congress 2012 are available to members online:

> Photos     > Presentations

Join the Giant Intracranial Aneurysm Registry
7 January, 2013 - 15:21

The registry collects data on how patients present, types of therapies and patients' health status.

> Find out more